SCHEMBL28396378

SCHEMBL28396378

CC(C)(C)OC(=O)Nc1nc(CC(=O)N2CCN(c3ccccc3)CC2)cs1

nearest known ligand 0.59

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 1/20 0.49
MAPT P10636 4/20 0.46
LMNA P02545 3/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ALDH1A1 P00352 3/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD11B1 P28845 2/20 0.44
HSD17B1 P14061 1/20 0.44
HSD17B2 P37059 1/20 0.44
F2 P00734 4/20 0.44
F10 P00742 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30932919 0.86 HSD11B1 (0.52) SIRT1LMNASMN1; SMN2HSD11B1HSD17B1
SCHEMBL20640299 0.85 MAPT (0.51) MAPTLMNAHTTSMN1; SMN2ALDH1A1
SCHEMBL20649327 0.83 SIRT1 (0.46) SIRT1SMN1; SMN2ALDH1A1HSD11B1HSD17B1
SCHEMBL28696760 0.82 SIRT1 (0.45) SIRT1MAPTLMNAHTTSMN1; SMN2
SCHEMBL3538448 0.81 F2 (0.63) SIRT1LMNASMN1; SMN2HSD11B1HSD17B1
SCHEMBL4832528 0.81 ACKR3 (0.47) MAPTMEN1KMT2A
SCHEMBL20649166 0.80 SIRT1 (0.46) SIRT1SMN1; SMN2HSD11B1HSD17B1HSD17B2
SCHEMBL28391886 0.80 F2 (0.55) SIRT1LMNAALDH1A1MEN1KMT2A
SCHEMBL3537265 0.79 F10 (0.66) SIRT1LMNASMN1; SMN2HSD11B1HSD17B1
SCHEMBL19820646 0.78 F2 (0.53) SIRT1MAPTSMN1; SMN2ALDH1A1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110997678-B Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2023-02-21 CN disclosed
CN-110997678-A Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2020-04-10 CN disclosed